You are here

Justice News

Department of Justice
U.S. Attorney’s Office
District of Connecticut

FOR IMMEDIATE RELEASE
Friday, January 3, 2020

New Haven Oxycodone Dealer is Sentenced

John H. Durham, United States Attorney for the District of Connecticut, announced that MILTON VEREEN, also known as “M.D.,” 40, of New Haven, was sentenced today by U.S. District Judge Vanessa L. Bryant in Hartford to 12 months and one day of imprisonment, followed by five years of supervised release, for distributing oxycodone.

According to court documents and statements made in court, in June 2017, the FBI’s New Haven Safe Streets/Gang Task Force initiated an investigation into a New Haven drug trafficking organization headed by Jermayne Butler.  The investigation, which included physical surveillance, 13 controlled purchases of narcotics, and court-authorized wiretaps on multiple phones, revealed that members of the organization were distributing crack cocaine and oxycodone in and around New Haven.  Vereen was an oxycodone distributor who sometimes redistributed oxycodone supplied to him by Butler and, at other times, supplied Butler with oxycodone.

Butler, Vereen and several other members of the organization were arrested on federal criminal complaints on February 6, 2018.  On February 8, 2018, a grand jury in New Haven returned a 30-count indictment charging 19 individuals with various offenses.

On April 25, 2019, Vereen pleaded guilty to one count of conspiracy to distribute, and to possess with intent to distribute, oxycodone.  Vereen, who is released on a $50,000 bond, is required to report to prison on March 17, 2020.

Butler pleaded guilty on August 9, 2019, and awaits sentencing.

This matter is being investigated by the FBI’s New Haven Safe Streets/Gang Task Force, which includes members from the New Haven Police Department, Milford Police Department, West Haven Police Department and Connecticut Department of Correction.  The case is being prosecuted by Assistant U.S. Attorneys Patrick F. Caruso and David C. Nelson.

Topic(s): 
Drug Trafficking
Opioids
Prescription Drugs
Component(s): 
Updated January 3, 2020